Why Calidi Biotherapeutics (CLDI) Shares Are Trading Lower
Why Calidi Biotherapeutics (CLDI) Shares Are Trading Lower
Calidi Biotherapeutics Inc (NASDAQ:CLDI) shares are trading lower by 14.3% to $0.17 during Monday's session after the company announced a 1-for-10 reverse stock split, effective at 12:01 a.m. Eastern Time on July 15. The company's common stock will begin trading on a split-adjusted basis on the NYSE American market under the symbol "CLDI".
在週一的交易中，Calidi Biotherapeutics Inc (納斯達克：CLDI) 股價下跌14.3%，至0.17美元，此前該公司宣佈了1股拆爲10股的逆向股票分割，將於7月15日東部時間上午12:01生效。公司普通股會以股票分割後的調整價格在紐約美國證券交易所開始交易，標的爲 "CLDI"。
The reverse stock split was approved by the company's stockholders at a Special Meeting on June 6, and finalized by the Board on July 1. As a result, the number of issued and outstanding shares of common stock will be reduced to one-tenth of the pre-split amount, with fractional shares rounded up to the nearest whole share. The reverse stock split will not change the number of authorized shares or the par value per share.
該逆向股票分割已於6月6日的特別會議獲得公司股東的批准，並於7月1日由董事會最終確定。因此，發行和流通股份將減少到拆分前的十分之一，碎股將四捨五入至最接近的整股。逆向股票分割不會改變授權股份的數量或每股的面值。
Read Also: Paramount Analysts Size Up Merger: Skydance Aims For Earnings, 'Not A Breakup,' Redstone Says Content Is King
閱讀原文：派拉蒙分析師對合並進行規模化評估：Skydance以收益爲目標，“不是分手”，Redstone表示“內容爲王”
Should I Sell My CLDI Stock?
我應該賣出我的CLDI股票嗎？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在決定持有或出售股票時，投資者應考慮他們的投資期限、未實現收益和總回報。
Shares of Calidi Biotherapeutics have fallen 18.15% over the past month, meaning an investor who bought shares on Jun. 1 would see a capital loss of $0.05.
過去一個月，Calidi Biotherapeutics的股價已下跌18.15%，這意味着一個在6月1日購買股票的投資者將會承擔0.05美元的資本損失。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Calidi Biotherapeutics stock currently has an RSI of 56.14, indicating neutral conditions.
投資者也可以考慮市場動態。相對強弱指標可用於指示股票是否超買或超賣。Calidi Biotherapeutics股票目前的相對強弱指標爲56.14，說明中立的情況。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
獲取先進的圖表和分析工具以及股票數據，請查看Benzinga PRO。免費試用。
CLDI has a 52-week high of $5.00 and a 52-week low of $0.14.
CLDI的52周最高價爲5.00美元，52周最低價爲0.14美元。
譯文內容由第三人軟體翻譯。